New insider activity at Tango Therapeutics ( (TNGX) ) has taken place on September 29, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Significant shareholder Third Rock Ventures IV, L.P. has offloaded 500,000 shares of Tango Therapeutics stock, amounting to a total transaction value of $4,005,000.
Spark’s Take on TNGX Stock
According to Spark, TipRanks’ AI Analyst, TNGX is a Neutral.
Tango Therapeutics’ overall stock score is primarily impacted by its weak financial performance, characterized by declining revenues and persistent losses. While technical indicators show some positive momentum, the negative valuation metrics and recent executive resignation add to the uncertainty. The company needs to address its financial and operational challenges to improve its stock attractiveness.
To see Spark’s full report on TNGX stock, click here.
More about Tango Therapeutics
YTD Price Performance: 172.52%
Average Trading Volume: 1,950,353
Technical Sentiment Signal: Buy
Current Market Cap: $949M